J-REIT Data

3308

Nippon Healthcare Investment Corporation: Offer Price of 150,000 yen per Unit

(Oct. 27, 2014)

Nippon Healthcare Investment Corporation announces the offer price of 150,000 yen per unit for the new investment units and the secondary offering of investment units. Amount of funding is about 5.9 billion yen. Expected dividend per unit(including dividend in excess of net income) for the 2nd period(Nov 1, 2014 - Apr 30, 2015) is 2,900 yen.

   
  2th period (forecast)
Operating revenues 507 million JPY
Net income 126 million JPY
Dividend per unit
(Not including dividend
in excess of net income)
2,075 JPY
Dividend in excess of net income 825 JPY
Dividend per unit
(Including dividend
in excess of net income)
2,900 JPY
   
  3th period (forecast)
Operating revenues 511 million JPY
Net income 181 million JPY
Dividend per unit
(Not including dividend
in excess of net income)
2,982 JPY
Dividend in excess of net income 768 JPY
Dividend per unit
(Including dividend
in excess of net income)
3,750 JPY

Recent 5 news of
Nov. 5, 2014
Nippon Healthcare Investment Corporation : Listing on TSE REIT Market on Nov 5
Oct. 1, 2014
Nippon Healthcare Investment Corporation to be listed on the TSE REIT Market on Nov 5

ReitInfo.com

Property Acquisition Price Rankings

(Billions of yen)

1 Shinjuku Mitsui Bldg. 170
2 IIDABASHI GRAND BLOOM 139
3 Roppongi Hills Mori Tower 115
4 Shiodome Building 107
5 Tokyo Shiodome Building 83
Unit Price Growth Rankings
1 Global One +1.90%
2 Kenedix REIT +1.66%
3 Hulic Reit +1.58%
* This website provides information and data on J-REITs and is not intended as a solicitation for investment.
* The information appearing on this website has been carefully vetted, but the accuracy of the content is in no way guaranteed and may change without notice (that is, it may be modified or deleted).
* Users shall be responsible for the use of the information published on this website. The Company cannot be held liable whatsoever regarding the use of this information.
* Copyrights related to the information published on this website belong to the Company. The unauthorized use (diversion or reproduction, etc.) of this information is strictly prohibited.